Abstract |
Striatal dopamine loss in Parkinson's disease is accompanied by a dysregulation of corticostriatal glutamatergic neurotransmission. Within this study, we investigated striatal expression and activity of the glial high-affinity Na(+)/K(+)-dependent glutamate transporters, GLT-1 and GLAST, in the 6-hydroxydopamine hemi-Parkinson rat model at different time points after unilateral 6-hydroxydopamine injection into the medial forebrain bundle. Using semi-quantitative Western blotting and an ex vivo D-[(3)H]- aspartate uptake assay, we showed a time-dependent bilateral effect of unilateral 6-hydroxydopamine lesioning on the expression as well as activity of GLT-1. At 3 and 12 weeks post-lesion, striatal GLT-1 function was bilaterally upregulated whereas at 5 weeks there was no change. Even though our data do not allow a straightforward conclusion as for the role of glutamate transporters in the pathogenesis of the disease, they do clearly demonstrate a link between disturbed glutamatergic neurotransmission and glutamate transporter functioning in the striatum of a rat model for Parkinson's disease.
|
Authors | Ann Massie, Stéphanie Goursaud, Anneleen Schallier, Katia Vermoesen, Charles K Meshul, Emmanuel Hermans, Yvette Michotte |
Journal | Neurochemistry international
(Neurochem Int)
Vol. 57
Issue 5
Pg. 572-8
(Nov 2010)
ISSN: 1872-9754 [Electronic] England |
PMID | 20643175
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 Elsevier Ltd. All rights reserved. |
Chemical References |
- Excitatory Amino Acid Transporter 1
- Excitatory Amino Acid Transporter 2
- Piperazines
- Slc1a2 protein, rat
- Slc1a3 protein, rat
- Aspartic Acid
- Oxidopamine
- 1-(2 (diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine
- Dopamine
|
Topics |
- Animals
- Aspartic Acid
(metabolism)
- Blotting, Western
- Chromatography, High Pressure Liquid
- Corpus Striatum
(metabolism, physiology)
- Dopamine
(metabolism)
- Excitatory Amino Acid Transporter 1
(biosynthesis, genetics)
- Excitatory Amino Acid Transporter 2
(biosynthesis, genetics, physiology)
- Immunohistochemistry
- Medial Forebrain Bundle
(metabolism, physiology)
- Oxidopamine
- Parkinson Disease, Secondary
(chemically induced, physiopathology)
- Piperazines
(metabolism)
- Rats
- Synaptosomes
(metabolism)
- Time Factors
|